Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials

Autor: Hauschild, Axel, Ascierto, Paolo A., Schadendorf, Dirk, Grob, Jean Jacques, Ribas, Antoni, Kiecker, Felix, Dutriaux, Caroline, Demidov, Lev V., Lebbé, Céleste, Rutkowski, Piotr, Blank, Christian U., Gutzmer, Ralf, Millward, Michael, Kefford, Richard, Haas, Tomas, D'Amelio, Anthony, Jr., Gasal, Eduard, Mookerjee, Bijoyesh, Chapman, Paul B.
Zdroj: In European Journal of Cancer January 2020 125:114-120
Databáze: ScienceDirect
Externí odkaz: